Epigenetic and Epitranscriptomic Control in Prostate Cancer

The initiation of prostate cancer has been long associated with DNA copy-number alterations, the loss of specific chromosomal regions and gene fusions, and driver mutations, especially those of the Androgen Receptor. Non-mutational events, particularly DNA and RNA epigenetic dysregulation, are emerg...

Full description

Bibliographic Details
Main Authors: Judith López, Ana M. Añazco-Guenkova, Óscar Monteagudo-García, Sandra Blanco
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/2/378
_version_ 1797479839778734080
author Judith López
Ana M. Añazco-Guenkova
Óscar Monteagudo-García
Sandra Blanco
author_facet Judith López
Ana M. Añazco-Guenkova
Óscar Monteagudo-García
Sandra Blanco
author_sort Judith López
collection DOAJ
description The initiation of prostate cancer has been long associated with DNA copy-number alterations, the loss of specific chromosomal regions and gene fusions, and driver mutations, especially those of the Androgen Receptor. Non-mutational events, particularly DNA and RNA epigenetic dysregulation, are emerging as key players in tumorigenesis. In this review we summarize the molecular changes linked to epigenetic and epitranscriptomic dysregulation in prostate cancer and the role that alterations to DNA and RNA modifications play in the initiation and progression of prostate cancer.
first_indexed 2024-03-09T21:51:34Z
format Article
id doaj.art-28704f64237a4372b2122c7c1228bef6
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-09T21:51:34Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-28704f64237a4372b2122c7c1228bef62023-11-23T20:05:53ZengMDPI AGGenes2073-44252022-02-0113237810.3390/genes13020378Epigenetic and Epitranscriptomic Control in Prostate CancerJudith López0Ana M. Añazco-Guenkova1Óscar Monteagudo-García2Sandra Blanco3Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)—University of Salamanca, 37007 Salamanca, SpainCentro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)—University of Salamanca, 37007 Salamanca, SpainCentro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)—University of Salamanca, 37007 Salamanca, SpainCentro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)—University of Salamanca, 37007 Salamanca, SpainThe initiation of prostate cancer has been long associated with DNA copy-number alterations, the loss of specific chromosomal regions and gene fusions, and driver mutations, especially those of the Androgen Receptor. Non-mutational events, particularly DNA and RNA epigenetic dysregulation, are emerging as key players in tumorigenesis. In this review we summarize the molecular changes linked to epigenetic and epitranscriptomic dysregulation in prostate cancer and the role that alterations to DNA and RNA modifications play in the initiation and progression of prostate cancer.https://www.mdpi.com/2073-4425/13/2/378epigeneticsDNA methylationhistone modificationsepitranscriptomicsRNA modificationsprostate cancer
spellingShingle Judith López
Ana M. Añazco-Guenkova
Óscar Monteagudo-García
Sandra Blanco
Epigenetic and Epitranscriptomic Control in Prostate Cancer
Genes
epigenetics
DNA methylation
histone modifications
epitranscriptomics
RNA modifications
prostate cancer
title Epigenetic and Epitranscriptomic Control in Prostate Cancer
title_full Epigenetic and Epitranscriptomic Control in Prostate Cancer
title_fullStr Epigenetic and Epitranscriptomic Control in Prostate Cancer
title_full_unstemmed Epigenetic and Epitranscriptomic Control in Prostate Cancer
title_short Epigenetic and Epitranscriptomic Control in Prostate Cancer
title_sort epigenetic and epitranscriptomic control in prostate cancer
topic epigenetics
DNA methylation
histone modifications
epitranscriptomics
RNA modifications
prostate cancer
url https://www.mdpi.com/2073-4425/13/2/378
work_keys_str_mv AT judithlopez epigeneticandepitranscriptomiccontrolinprostatecancer
AT anamanazcoguenkova epigeneticandepitranscriptomiccontrolinprostatecancer
AT oscarmonteagudogarcia epigeneticandepitranscriptomiccontrolinprostatecancer
AT sandrablanco epigeneticandepitranscriptomiccontrolinprostatecancer